ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

Abstracts From AACR Annual Meeting

May 28, 1976

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011

NCAB Approves Bypass Budget f $1.685 Billion for FY ’88, $200 Million More Than Asked For ‘87

May 30, 1986

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992